全文获取类型
收费全文 | 742985篇 |
免费 | 36019篇 |
国内免费 | 993篇 |
专业分类
耳鼻咽喉 | 9661篇 |
儿科学 | 23084篇 |
妇产科学 | 17312篇 |
基础医学 | 122290篇 |
口腔科学 | 19966篇 |
临床医学 | 61476篇 |
内科学 | 142437篇 |
皮肤病学 | 17781篇 |
神经病学 | 51814篇 |
特种医学 | 24713篇 |
外国民族医学 | 56篇 |
外科学 | 103176篇 |
综合类 | 8646篇 |
现状与发展 | 2篇 |
一般理论 | 155篇 |
预防医学 | 63421篇 |
眼科学 | 17340篇 |
药学 | 57461篇 |
1篇 | |
中国医学 | 2005篇 |
肿瘤学 | 37200篇 |
出版年
2021年 | 7339篇 |
2019年 | 7799篇 |
2018年 | 12655篇 |
2017年 | 8397篇 |
2016年 | 9085篇 |
2015年 | 10065篇 |
2014年 | 12379篇 |
2013年 | 18579篇 |
2012年 | 29469篇 |
2011年 | 32195篇 |
2010年 | 17320篇 |
2009年 | 14152篇 |
2008年 | 27807篇 |
2007年 | 30417篇 |
2006年 | 29136篇 |
2005年 | 28192篇 |
2004年 | 26720篇 |
2003年 | 25449篇 |
2002年 | 24478篇 |
2001年 | 28523篇 |
2000年 | 29690篇 |
1999年 | 24074篇 |
1998年 | 6133篇 |
1997年 | 4926篇 |
1996年 | 4985篇 |
1992年 | 16965篇 |
1991年 | 18095篇 |
1990年 | 18072篇 |
1989年 | 17401篇 |
1988年 | 16023篇 |
1987年 | 15786篇 |
1986年 | 14798篇 |
1985年 | 14181篇 |
1984年 | 10504篇 |
1983年 | 8930篇 |
1982年 | 4647篇 |
1979年 | 10106篇 |
1978年 | 7124篇 |
1977年 | 5904篇 |
1976年 | 6241篇 |
1975年 | 7462篇 |
1974年 | 8535篇 |
1973年 | 8313篇 |
1972年 | 7669篇 |
1971年 | 7380篇 |
1970年 | 6859篇 |
1969年 | 6498篇 |
1968年 | 6241篇 |
1967年 | 5580篇 |
1966年 | 4820篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Stepanova E. S. Makarenkova L. M. Chistyakov V. V. Rybakov Yu. L. Gukasov V. M. Fedotcheva T. A. Parshin V. A. Votyakov V. A. Shimanovskii N. L. 《Pharmaceutical Chemistry Journal》2019,52(12):1016-1020
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was... 相似文献
2.
3.
Novozhilov A. V. Mindukshev I. V. Korf E. A. Krivchenko A. I. Goncharov N. V. 《Bulletin of experimental biology and medicine》2020,168(4):444-448
Bulletin of Experimental Biology and Medicine - Ammonium, an end-product of catabolism, in low doses can promote adaptation of metabolic pathways in erythrocytes under conditions of extreme... 相似文献
4.
Ali Mobasheri Csaba Matta Ilona Uzielienè Emma Budd Pablo Martín-Vasallo Eiva Bernotiene 《Joint, bone, spine : revue du rhumatisme》2019,86(1):29-35
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development. 相似文献
5.
6.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
7.
8.
9.
Amosova E. N. Shilova I. V. Zueva E. P. Rybalkina O. Yu. 《Pharmaceutical Chemistry Journal》2020,54(7):721-724
Pharmaceutical Chemistry Journal - Three extracts were produced from the above-ground part of the meadowsweet Filipendula ulmaria (L.) Maxim. using water, 40% ethanol, and 70% ethanol. Comparative... 相似文献
10.